Effect of surgical intervention on circulating tumor cells in patients with squamous cell carcinoma of the head and neck using a negative enrichment technology

被引:20
|
作者
Jatana, Kris R. [1 ,2 ]
Balasubramanian, Priya [3 ]
McMullen, Kyle P. [2 ]
Lang, Jas C. [2 ]
Teknos, Theodoros N. [2 ]
Chalmers, Jeffrey J. [3 ]
机构
[1] Nationwide Childrens Hosp, Dept Pediat Otolaryngol Head & Neck Surg, Columbus, OH USA
[2] Ohio State Univ, Dept Otolaryngol Head & Neck Surg, Wexner Med Ctr, Columbus, OH 43210 USA
[3] Ohio State Univ, William G Lowrie Dept Chem & Biomol Engn, Columbus, OH 43210 USA
基金
美国国家科学基金会;
关键词
circulating tumor cell; squamous cell carcinoma; surgery; immunomagnetic separation; EPITHELIAL-MESENCHYMAL TRANSITION; LYMPH-NODE METASTASIS; BONE-MARROW; CANCER PATIENTS; LUNG-CANCER; PROGNOSTIC-SIGNIFICANCE; PERIPHERAL-BLOOD; BREAST-CANCER; DISSEMINATION; RISK;
D O I
10.1002/hed.24519
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background. The purpose of this study was to investigate the impact of surgical intervention on detection of circulating tumor cells (CTCs) in patients with squamous cell carcinoma of the head and neck (SCCHN.) Methods. We utilized a negative depletion technique to identify cytokeratin (CK)-positive CTCs. The numbers of CTCs immediately before and after surgical resection were compared. Results. Seventy-six blood samples from 38 patients with SCCHN were examined. Seventy-nine percent of the patients had CTCs detected before and after surgery. A total of 7.89% had no CTCs before surgery, yet had CTCs identified after surgery. Overall, 60.5% of patients had an increased number of CTCs/mL after surgery with a mean increase of 6.63-fold. A statistically significant increase in CTCs was seen after surgery (p = .02). Conclusion. The timing of sample collection in patients with SCCHN who have surgical intervention can potentially impact the number of CTCs identified. (C) 2016 Wiley Periodicals, Inc.
引用
收藏
页码:1799 / 1803
页数:5
相关论文
共 50 条
  • [11] Measurement of circulating tumor cells in squamous cell carcinoma of the head and neck and patient outcomes
    Morgan, T. M.
    Wang, X.
    Qian, X.
    Switchenko, J. M.
    Nie, S.
    Patel, K. R.
    Cassidy, R. J.
    Shin, D. M.
    Beitler, J. J.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2019, 21 (03): : 342 - 347
  • [12] Circulating tumor cells as biomarkers of head and neck squamous cell carcinoma: an updated view
    Mangano, Alberto
    Mangano, Alessandro
    Lianos, Georgios D.
    Levrini, Luca
    Picone, Monica
    Boni, Luigi
    Dionigi, Gianlorenzo
    FUTURE ONCOLOGY, 2015, 11 (13) : 1851 - 1853
  • [13] Identification of circulating tumor cells: a prognostic marker in squamous cell carcinoma of the head and neck?
    Jatana, Kris R.
    Lang, Jas C.
    Chalmers, Jeffrey J.
    FUTURE ONCOLOGY, 2011, 7 (04) : 481 - 484
  • [14] The clinical relevance of circulating tumor cell size in head and neck squamous cell carcinoma patients
    Woo, Hyeongjung
    Shin, Hyun Young
    Oh, So Yeon
    Lee, Sun Min
    Kim, Minseok S.
    CLINICAL CANCER RESEARCH, 2024, 30 (21)
  • [15] Detection of Circulating Tumor Cell Subpopulations in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC)
    Weller, Patrick
    Nel, Ivonne
    Hassenkamp, Philipp
    Gauler, Thomas
    Schlueter, Anke
    Lang, Stephan
    Dountsop, Paulette
    Hoffmann, Andreas-Claudius
    Lehnerdt, Goetz
    PLOS ONE, 2014, 9 (12):
  • [16] Molecular phenotypes of circulating tumor cells and efficacy of nivolumab treatment in patients with head and neck squamous cell carcinoma
    Tada, Hiroe
    Takahashi, Hideyuki
    Kawabata-Iwakawa, Reika
    Nagata, Yurino
    Uchida, Miho
    Shino, Masato
    Ida, Shota
    Mito, Ikko
    Matsuyama, Toshiyuki
    Chikamatsu, Kazuaki
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [17] Molecular phenotypes of circulating tumor cells and efficacy of nivolumab treatment in patients with head and neck squamous cell carcinoma
    Hiroe Tada
    Hideyuki Takahashi
    Reika Kawabata-Iwakawa
    Yurino Nagata
    Miho Uchida
    Masato Shino
    Shota Ida
    Ikko Mito
    Toshiyuki Matsuyama
    Kazuaki Chikamatsu
    Scientific Reports, 10
  • [18] Detection and molecular characterization of circulating tumor cells in advanced head and neck squamous cell carcinoma
    Tada, Hiroe
    Takahashi, Hideyuki
    Ishii, Hiroki
    Kuwabara-Yokobori, Yuki
    Shino, Masato
    Chikamatsu, Kazuaki
    CANCER RESEARCH, 2019, 79 (13)
  • [19] Tumor record for patients with squamous cell carcinoma of the head and neck
    Gimeno, CM
    1ST WORLD CONGRESS ON HEAD AND NECK ONCOLOGY, 1998, : 1271 - 1273
  • [20] Individualized circulating tumor DNA monitoring in head and neck squamous cell carcinoma
    Kogo, Ryunosuke
    Manako, Tomomi
    Iwaya, Takeshi
    Nishizuka, Satoshi
    Hiraki, Hayato
    Sasaki, Yasushi
    Idogawa, Masashi
    Tokino, Takashi
    Koide, Ayaka
    Komune, Noritaka
    Yasumatsu, Ryuji
    Nakagawa, Takashi
    CANCER MEDICINE, 2022, 11 (21): : 3960 - 3968